Ucrest Berhad Enters into Distribution Agreement with Seecure Holding Corporation
Seecure currently has over 800 accounts and it has been growing very rapidly. It is expected to grow exponentially to 5,000 - 10,0000 accounts in 2025 with the expansion of distribution channels both online and offline. iMedicTM is made available to these customers immediately. The duration of the Agreement is five (5) years. The commencement date and expiry date of the Agreement are 3 July 2024 and 2 July 2029 respectively. The renewal term is not specified in the Agreement. RATIONALE, BENEFIT AND PROSPECT: UCrest and Seecure share the vision that empowering patients to manage their own health with remote monitoring and escalation to the doctors when abnormality is detected by the AI engine in iMedicTM. RISK FACTORS: UCrest does not foresee any significant risks other than foreign currency risk associated with the Agreement.